This is a limited opportunity to own an equity stake in Chattanooga Football Club. Supporter shares are limited to 8,000. This is real equity with real rights—each share comes with life-long voting rights and special owner privileges.

We have inspired dozens of community-based clubs throughout the United States, giving them hope that soccer can thrive in places we never thought possible. A successful raise will set an example and pave the way for other clubs and cities across America.  

By becoming an owner, you’re not just investing in the local soccer community, as shareholder of a benefit corporation, you’re buying a piece of U.S. soccer history.

Founded by Emmy-winning digital media pioneers.

One of the most successful companies in JOBS Act History, with more than 10,000 investors, a worldwide community of 40,000, and more than $5 million raised. 

Projects include Mandy (Nicolas Cage), Colossal (Anne Hathaway, Jason Sudeikis), Bad Samaritan (David Tennant) and a slate of original projects including a groundbreaking virtual reality series with Stan Lee and Kevin Smith.

Partnerships with Whole Foods, Target, Total Wine & More, Cost Plus, Sprouts, BevMo! In fact, we are now being sold in Raley's, Sprouts, Nob Hill Foods, Cost Plus World Market and Total Wine & More.

Sold in more than 150 California stores and 30 bars and restaurants less than a year after launch and recently opened distributor accounts in Oregon. 

Successfully raised $204,565 from 288 Wefunder investors in July 2017.

1. First to produce year-round pesticide-free spinach.

1. Grown from 1 retailer shelf to 12 high-end retailer shelves in 6 months.

1. Use 90% less water and yield 20x more greens per sq ft than conventional farming. 

CEO's prior two companies were acquired by Qualcomm and Apple, with technologies now standards in the industry.

Over $30M of non-dilutive funding (peer-reviewed grants rewarding innovation above 'hot' target trends) has driven the research and development.

Extensive evidence, including a proof-of-concept study in humans, showing a reversal of PN through 1) nerve regrowth, 2) reduced symptoms, and 3) return of quality-of-life to patients.

PROVEN SALES: $8M+ lifetime revenue; expected $3M revenue for 2018

PROVEN GROWTH: 42-152% year-over-year growth

PROVEN PROFITABILITY: Net income positive 5 consecutive years since launch in 2013.

Founder has been working in space for 25+ years 

Drug is highly innovative and first of its kind 

No addictive potential because drug is locally delivered and won't enter the brain

On track for $3.5M in sales this year, up from $1.17M in 2017. 

Grown 100+ percent each year since launch.

Raised $968K in pre-seed round.

Raised $1.29M from 727 investors on Wefunder in 2017. 

Since then, DARPA awarded a Phase 2 $2.5M development contract in October 2017, a follow-on to our 2 DoD contracts, totaling $5.5M in non-dilutive funding. 

New engine architecture could improve fuel efficiency by up to 2x over a gasoline engine while reducing size and weight by up to 10x over a diesel engine.